CD46-induced human Treg enhance B-cell responses
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Regulatory CD4+ T cells (Treg) are important modulators of the immune response. Different types of Treg have been identified based on whether they are thymically derived (natural Treg) or induced in the periphery (adaptive Treg). We recently reported on an adaptive Treg phenotype that can be induced by the concomitant stimulation of human CD4+ T cells through CD3 and the membrane complement regulator CD46. These complement (CD46)‐induced regulatory T cells (cTreg) potently inhibit bystander T‐cell proliferation through high‐level secretion of IL‐10. In addition, cTreg express granzyme B and exhibit cytotoxic effects toward activated effector T cells. Here, we analyzed the effect of cTreg on B‐cell functions in a co‐culture system. We found that cTreg enhance B‐cell Ab production. This B‐cell support is dependent on cell/cell contact as well as cTreg‐derived IL‐10. In addition, we show that T cells from a CD46‐deficient patient are not capable of promoting B‐cell responses, whereas CD46‐deficient B cells have no intrinsic defect in Ig production. This finding may relate to a subset of CD46‐deficient patients, who present with common variable immunodeficiency. Thus, the lack of cTreg function in optimizing B‐cell responses could explain why some CD46‐deficient patients develop common variable immunodeficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite these diverse functions, the survival of human B cells does not depend on its expression even in vivo [19].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318 · cited 1×
“CD46 costimulation did not induce significantly different expression levels of the costimulatory and activation markers CD40L, CD28, CTLA-4, CD200, OX40, and ICOS [28, 29] (Figure 4A and not shown).”
BackgroundRegulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586
Research works printed but not linked: 48
- 10.1084/jem.163.4.837 · DOI · Paper page
- 10.1128/JVI.78.9.4385-4388.2004 · DOI · Paper page
- 10.1038/nri1994 · DOI · Paper page
- 10.1016/j.it.2004.07.004 · DOI · Paper page
- 10.4049/jimmunol.164.12.6091 · DOI · Paper page
- 10.1002/eji.200324259 · DOI
- 10.1038/nature01315 · DOI · Paper page
- 10.1016/j.immuni.2004.09.002 · DOI · Paper page
- 10.1385/IR:32:1-3:031 · DOI
- 10.1182/blood-2005-07-2951 · DOI
- 10.1038/nri1032 · DOI · Paper page
- 10.1146/annurev.immunol.16.1.619 · DOI · Paper page
- 10.1006/smim.1997.0080 · DOI
- 10.1084/jem.183.3.937 · DOI · Paper page
- 10.1126/science.3107127 · DOI · Paper page
- 10.4049/jimmunol.174.4.1783 · DOI · Paper page
- 10.1182/blood-2004-03-0859 · DOI · Paper page
- 10.1182/blood-2005-11-4502 · DOI · Paper page
- 10.1182/blood-2005-10-007252 · DOI · Paper page
- 10.1681/ASN.2005101051 · DOI · Paper page
- 10.1146/annurev.med.59.060106.185110 · DOI
- 10.1016/S0140-6736(08)61199-X · DOI · Paper page
- 10.1084/jem.183.1.77 · DOI
- 10.4049/jimmunol.181.4.2544 · DOI
- 10.4049/jimmunol.167.12.6780 · DOI
- 10.1053/j.ajkd.2008.02.359 · doi:10.1053/j.ajkd.2008.02.359
- 10.1681/ASN.2006080811 · doi:10.1681/asn.2006080811
- 10.1016/S1471-4906(02)02223-8 · DOI · Paper page
- 10.1016/S1359-6101(03)00025-X · DOI · Paper page
- 10.1172/JCI200423395 · DOI · Paper page
- O'Garra A., 2004, IL‐10‐producing and naturally occurring CD4+Tregs: limiting collateral damage, J. Clin. Invest., 114, 1372, 10.1172/JCI23215 · doi:10.1172/jci23215 · Paper page
- 10.1172/JCI200423238 · DOI · Paper page
- 10.1038/39614 · DOI · Paper page
- 10.1084/jem.20011629 · DOI · Paper page
- 10.1182/blood-2004-03-1211 · DOI · Paper page
- 10.1002/eji.200737271 · DOI · Paper page
- 10.4049/jimmunol.175.2.677 · DOI · Paper page
- 10.1172/JCI29251 · DOI · Paper page
- 10.1042/bj3300163 · DOI · Paper page
- 10.1038/ni810 · DOI · Paper page
- 10.1016/j.intimp.2009.01.034 · DOI
- 10.4049/jimmunol.181.7.5158 · DOI · Paper page
- 10.4049/jimmunol.181.7.4752 · DOI
- 10.1084/jem.20051511 · DOI · Paper page
- Lim H. W., 2005, Cutting edge: direct suppression of B cells by CD4+CD25+regulatory T cells, J. Immunol., 175, 4180, 10.4049/jimmunol.175.7.4180 · DOI · Paper page
- 10.4049/jimmunol.181.7.4447 · DOI
- 10.1201/b14212 · DOI · Paper page
- 10.1074/jbc.M004650200 · DOI · Paper page
Cited by
Facciotti, F., Gagliani, N., Häringer, B., Alfen, J. S., Penatti, A., Maglie, S., Paroni, M., Iseppon, A., Moro, M., Crosti, M. C., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.06.044 · Cited by 43
Akidil, E., Albanese, M., Buschle, A., Ruhle, A., Pich, D., Keppler, O. T., & Hammerschmidt, W. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009117 · Cited by 31
Metadata
- Authors
- Fuchs, A., Atkinson, J. P., Fremeaux‐Bacchi, V., & Kemper, C.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2009-10-30
- Volume
- 39
- Issue
- 11
- Pages
- 3097-3109
- ISSN
- 0014-2980
- 1521-4141
- Cited by
- 42
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD46-induced human Treg enhance B-cell responses. https://app.cochat.ai/papers/10.1002/eji.200939392
- The paper
- Fuchs, A., Atkinson, J. P., Fremeaux‐Bacchi, V., & Kemper, C. (2009). CD46-induced human Treg enhance B-cell responses. European Journal of Immunology. https://doi.org/10.1002/eji.200939392
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.